For the quarter ending 2026-03-31, CABA had $33,653K increase in cash & cash equivalents over the period. -$42,561K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -43,515 | -41,919 | -44,866 | -81,071 |
| Stock-based compensation | 5,256 | 4,258 | 5,815 | 10,866 |
| Depreciation | 337 | 348 | 345 | 953 |
| Non-cash finance lease expense | 4,022 | 3,334 | 3,479 | 4,884 |
| Non-cash operating lease expense | 978 | 953 | 931 | 1,787 |
| Accretion of operating lease liabilities | 81 | 106 | 117 | 309 |
| Amortization of discount on investments | 368 | 890 | 630 | 35 |
| Loss on foreign currency exchange rates | 19 | 79 | 85 | 61 |
| Prepaid expenses and other current assets | 409 | 642 | 905 | 1,012 |
| Other assets | 114 | 1,552 | 1,105 | 209 |
| Accounts payable | -269 | -1,706 | 1,070 | 2,186 |
| Accrued Liabilities And Other Operating Liabilities | -7,281 | 3,053 | 2,312 | 2,067 |
| Lease liabilities | -1,057 | -1,057 | -1,056 | -2,114 |
| Accrued interest payable under finance lease | - | - | -101 | 100 |
| Interest Payable Net | -241 | 291 | - | - |
| Net cash used in operating activities | -42,561 | -35,343 | -34,509 | -61,228 |
| Purchases of property and equipment | 0 | 205 | 78 | 946 |
| Purchases of investments | - | 0 | 50,002 | 49,035 |
| Proceeds from maturities of investments | 50,960 | 50,000 | 0 | 0 |
| Net cash (used in) provided by investing activities | 50,960 | 49,795 | -50,080 | -49,981 |
| Issuance of common stock from atm offering, net of sales agent commission and fees | 22,568 | 12,745 | - | - |
| Proceeds from the issuance of common stock under employee stock purchase plan | - | 94 | 0 | 197 |
| Proceeds from the issuance of common stock, warrants and pre-funded warrants, net of issuance costs | 6,938 | 0 | -25 | 93,583 |
| Issuance of common stock from atm offering, net of sales agent commission and fees | - | - | 0 | 2,595 |
| Proceeds from issuance of common stock in connection with the exercise of stock options | 32 | 0 | 14 | 0 |
| Principal payments on finance leases | 4,271 | 1,912 | 795 | 3,554 |
| Net cash provided by financing activities | 25,267 | 8,332 | -806 | 92,821 |
| Effect of exchange rate changes on cash and cash equivalents | -13 | -8 | -11 | 38 |
| Net decrease in cash and cash equivalents | 33,653 | 22,776 | -85,406 | -18,350 |
| Cash and cash equivalentsbeginning of period | 82,982 | 103,756 | 163,962 | - |
| Cash and cash equivalentsend of period | 116,635 | 22,776 | 60,206 | - |
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)